Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial

🌐 Nature — 2026-05-12

A groundbreaking phase 1 trial discusses the use of personalized multivalent neoantigen DNA vaccination aimed at treating glioblastoma. This innovative approach represents a significant advancement in cancer therapy.

Health AI & Tech cancer therapy DNA vaccination glioblastoma clinical trial personalized medicine

Read original source →

Teenager fighting for life after stabbing west of Brisbane
The Sydney Morning Herald — 2026-05-24
Bebê deixa hospital com coração novo após 7 meses de internação às pressas em SC: 'Gratidão por toda a vida'
Globo — 2026-05-24
82 killed in Shanxi mining blast: China thanks PM Modi for condolences
The Times of India — 2026-05-24
Rescuers search for two still missing after China mine blast kills 82
Channel NewsAsia — 2026-05-24
Yemen war sees scramble for scant resources between displaced and locals
Al Jazeera — 2026-05-24
Man dies after shark attack in Queensland
The Sydney Morning Herald — 2026-05-24

Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial

AI Summary

Related Articles

Teenager fighting for life after stabbing west of Brisbane

Bebê deixa hospital com coração novo após 7 meses de internação às pressas em SC: 'Gratidão por toda a vida'

82 killed in Shanxi mining blast: China thanks PM Modi for condolences

Rescuers search for two still missing after China mine blast kills 82

Yemen war sees scramble for scant resources between displaced and locals

Man dies after shark attack in Queensland